Testing effectiveness (Phase 2)WithdrawnNCT03377426
What this trial is testing
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)
Who this might be right for
Complicated Urinary Tract Infections
Novartis Pharmaceuticals